跳轉至內容
Merck

Cannabidiol--recent advances.

Chemistry & biodiversity (2007-08-23)
Raphael Mechoulam, Maximilian Peters, Eric Murillo-Rodriguez, Lumír O Hanus
摘要

The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non-psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly attractive therapeutic entity.

材料
產品編號
品牌
產品描述

Supelco
大麻二酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
大麻二酚标准液 溶液, 1.0 mg/mL in methanol, analytical standard, for drug analysis
Supelco
大麻二酚标准液 溶液, ~10 mg/mL in ethanol, analytical standard, for drug analysis